Member Info for itsallamess

Yes indeed 15 quid a share would be life changing

For the moment I will keep my feet firmly on the ground. I'm looking at a conservative figure based on Traumakine alone

The SP was 8.50 based on this going to market but now we know it works for 30% of ARDS paitents... for the moment so a sp of 3 quid is easily realistic once final confirmation is in.

That said I've not even factored in Clevergen Or a partner on board

So If the SP reflected 3 quid ATM I would be very happy :)

Not sure where we are heading

With carte Blanche rights to dilute when they want we could be stuck here forever

Did anyone else note that colin went part time and was looking for other oppotunites but ended manipulating things to get back on full time as no one would give him a job?

Give them credit for consistency.. not all i suspect are paid rampers but rather PIs so far down and with such large paper losses they just have to have PREM succeed!

I'm in a few dogs and bought in because i believed the rampers... so you get what you deserve but don't like to see folk loss out big time!

AIM is a cesspit of robbing CEOs

Latest interview we were told partners are interested and contacted! Who could they be? Someone who they have worked with in the past?

Consider this:

In 2017 lundbeck made €2.3 billion euros after expenses.
In March 2018, the company acquired Prexton Therapeutics for up to €905 million euros

They already have a realtionship with partnering and buying out other pharma companies and have a realtionship with our CEO

Jalkanen was the founder, CEO and President of BioTie Therapies, the first publicly traded biotech-company in Finland
Biotie has partnering agreements with H. Lundbeck A/S and UCB.
In January 2016, Acorda Therapeutics acquired Biotie Therapies for $363 million

Could the same partners that our CEO was in a JV with before in his other company he later sold be intrested in partnering with his new company FARN?

Remember though that there is only 31 million shares of which 32% are not in public hands

So only about 20 million shares out there up for grabs at the right price

Also in the interview it seems he is heading for a partner rather to carry us forward, nothing said about dilution.

Even if dilution ewes on the cards, so what.. the hard Work is done for Traumakine. Sub group identified, treatment for 1/3 of paitients is successful, no other treatment out there! Thats why this will be going to market

Also bear in kind our CEO said the results today are more importantly going to help get a partner.

Ive seen alot of bad CEOs on AIM and Makku doesnt seem like one of them. Very succesful in starting companies before and then partnering and selling them

FARN is the real deal, thats why it was worth 8.50 before...... yes they had this complication and yes the market is smaller but Traumakine works and the SP will reflect that soon.

For any newbies out there and any already invested as a reminder of what is happening here;

https://www.proactiveinvestors.co.uk/companies/amp/media_files/11455?__twitter_impression=true

Jap results any day now!

Authough we know thàt the results will be mixed due to the issues with corticosteroids. However I suspect they will cross examine the results with the new data carried out the YODA and other testing!

"The company continues to await top-line data from the Phase III ARDS trial with Japanese partner Maruishi (JapicCTI-163320) to help determine next steps for Traumakine's development. These data, originally expected before the end of year, are now anticipated by Faron in early 2019"

If i was suffering from ARDS and fell into the sub group I would be pushing for this treatment!

"The Company's lead candidate Traumakine, to prevent vascular leakage and organ failures, is currently the only treatment for Acute Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical trials and in 2017 received advice from US FDA to proceed directly to BLA submission following completion of EU and Japanese Phase III studies"

https://twitter.com/stocks_and/status/1090912774476177408?s=19

Good start

Nice steady rise today... News incoming! Expect an RNS this week!

Didn't really want to spend any more on MYN but this is as low as i think we will go so averaged down for a quick exit hopefully breaking even at .38

Below the placing

If they place so cheap it tells the market that the BOD only belivers this to be worth .12

At 2.4 then i will be happy to go.

Sad for ones locked in and either didnt have funds or want to throw more money at AST but some will of doubled there money here who bought in on the low.

This is a long painfull trip for many of us here.

Here's to a continued rise!

At least its some kind of communication... if funds are need they will have to issue more shares, but the SP needs to be higher!

Many a BB here on this websife arw full of 5/10% rampers that come and go as they make their small profit

Well this BB is testament to the LTH.

Same faces making tne rounds after a time wno have invested and are long term commitmen that farn will turn good.

Lots of good news on the horizon. In my book, gift horse if yo invest at these low prices!

Some sort of news should be soon!

Bottom we not gonna fold. Colin hutchinson isnt gonna get a job anywhere else with this kind of salary. He will make sure at least that gravy train continues!